WVE Wave Life Sciences Ltd

Wave Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.

$10.69  +0.66 (6.58%)
As of 03/02/2021 15:59:28 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
Singapore
11/11/2015
48,777,824
460,526
$489,241,575
0.00%
SEC Edgar Online
10-Q
10-K
Y95308105
SG9999014716
BYZG9R0

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-2.75
4.52
37.52
-164.35%
-1,364.40%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy